Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine.
about
Optimized construction of MUC1-VNTRn DNA vaccine and its anti-pancreatic cancer efficacyIn vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases modelPro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.Current immunotherapeutic approaches in pancreatic cancer.What is recent in pancreatic cancer immunotherapy?Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune ResponsesPotential targets for pancreatic cancer immunotherapeutics.MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge.Immunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer.Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.Retention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions.Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma.Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancer.
P2860
Q33599115-6DA50701-03EE-466B-BFA9-3A8F03F2F525Q33806343-4E54AFC9-B46E-4A08-AEE8-0B1071481347Q33918198-0CEE4C89-F20B-41EF-B378-EFBAFCC1A9C5Q35212837-EAE7AA2D-4BB6-41E4-8CFF-0AA3971E087FQ36665335-F8FCDB82-7766-4531-9CE8-770202B0E33CQ36815144-14CEB599-18AA-478C-BDA4-0C2F6C066F64Q37861220-E7D8EA4F-35BB-4EFA-8ABD-C5ED8DD18358Q38091088-7EA5CBC3-DE69-4FDD-A14D-160CE77B855BQ38221692-6919CE63-4FD1-4061-99C3-0DF2778D022FQ38741047-58C67EB1-30CE-4555-9B26-707DBEA12009Q39703930-0E439188-E92C-407B-8375-0089B2D8EF7BQ42040315-64B1390A-9299-4ED7-BFAE-C8CE0FBF7ED3Q45117306-5376D51D-2E99-4A72-AC03-2D0D4ABF1431
P2860
Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Induction of protective and th ...... econstructed MUC1 DNA vaccine.
@ast
Induction of protective and th ...... econstructed MUC1 DNA vaccine.
@en
type
label
Induction of protective and th ...... econstructed MUC1 DNA vaccine.
@ast
Induction of protective and th ...... econstructed MUC1 DNA vaccine.
@en
prefLabel
Induction of protective and th ...... econstructed MUC1 DNA vaccine.
@ast
Induction of protective and th ...... econstructed MUC1 DNA vaccine.
@en
P2093
P2860
P356
P1433
P1476
Induction of protective and th ...... econstructed MUC1 DNA vaccine.
@en
P2093
Danshong Wang
Dayong Jin
Tiantao Kuang
Wenchuan Wu
Wenhui Lou
Xiaoling Ni
Yefei Rong
P2860
P2888
P356
10.1186/1471-2407-9-191
P407
P577
2009-06-18T00:00:00Z
P5875
P6179
1011967086